Pemvidutide, developed by Altimmune, Inc., is a novel extended-duration dual agonist targeting both GLP-1 and glucagon
PLoS ONE 6 , e19657 (2011)
Within hepatology, recent milestones include the conditional approval of two pharmacological therapies for metabolic dysfunction-associated steatohepatitis (MASH) [4,5] , with several others in development
Incorporating lifestyle modifications, such as a balanced diet and regular exercise, enhances the effectiveness of tirzepatide
We embrace innovation and technology, nurture early-stage companies through our venture firm Catalyst by Wellstar and train future generations of caregivers with academic institutions including the Medical College of Georgia